Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Molecular Mechanism for Agonist-Promoted α2A-Adrenoceptor Activation by Norepinephrine and Epinephrine

Tommi Nyrönen, Marjo Pihlavisto, Juha M. Peltonen, Anna-Marja Hoffrén, Minna Varis, Tiina Salminen, Siegfried Wurster, Anne Marjamäki, Liisa Kanerva, Erja Katainen, Leif Laaksonen, Juha-Matti Savola, Mika Scheinin and Mark S. Johnson
Molecular Pharmacology May 2001, 59 (5) 1343-1354; DOI: https://doi.org/10.1124/mol.59.5.1343
Tommi Nyrönen
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjo Pihlavisto
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juha M. Peltonen
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna-Marja Hoffrén
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minna Varis
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiina Salminen
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siegfried Wurster
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Marjamäki
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liisa Kanerva
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erja Katainen
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leif Laaksonen
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juha-Matti Savola
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mika Scheinin
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark S. Johnson
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We present a mechanism for agonist-promoted α2A-adrenergic receptor (α2A-AR) activation based on structural, pharmacological, and theoretical evidence of the interactions between phenethylamine ligands and α2A-AR. In this study, we have: 1) isolated enantiomerically pure phenethylamines that differ both in their chirality about the β-carbon, and in the presence/absence of one or more hydroxyl groups: the β-OH and the catecholic meta- andpara-OH groups; 2) used [3H]UK-14,304 [5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine; agonist] and [3H]RX821002 [2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline; antagonist] competition binding assays to determine binding affinities of these ligands to the high- and low-affinity forms of α2A-AR; 3) tested the ability of the ligands to promote receptor activation by measuring agonist-induced stimulation of [35S]GTPγS binding in isolated cell membranes; and 4) used automated docking methods and our α2A-AR model to predict the binding modes of the ligands inside the α2A-AR binding site. The ligand molecules are sequentially missing different functional groups, and we have correlated the structural features of the ligands and ligand-receptor interactions with experimental ligand binding and receptor activation data. Based on the analysis, we show that structural rearrangements in transmembrane helix (TM) 5 could take place upon binding and subsequent activation of α2A-AR by phenethylamine agonists. We suggest that the following residues are important in phenethylamine interactions with α2A-AR: Asp113 (D3.32), Val114 (V3.33), and Thr118 (T3.37) in TM3; Ser200 (S5.42), Cys201 (C5.43), and Ser204 (S5.46) in TM5; Phe391 (F6.52) and Tyr394 (Y6.55) in TM6; and Phe411 (F7.38) and Phe412 (F7.39) in TM7.

Footnotes

    • Received August 25, 2000.
    • Accepted February 6, 2001.
  • Send reprint requests to: Dr. Mark S. Johnson, Department of Biochemistry and Pharmacy, Åbo Akademi University, Tykistökatu 6 A, FIN-20520 Turku, Finland. E-mail:johnson{at}abo.fi

  • This work was supported by the Academy of Finland, the Technology Development Center of Finland, Juvantia Pharma Ltd., and the Erna and Victor Hasselblad Foundation and by a computational grant from the Center for Scientific Computing (Espoo, Finland).

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 59 (5)
Molecular Pharmacology
Vol. 59, Issue 5
1 May 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Mechanism for Agonist-Promoted α2A-Adrenoceptor Activation by Norepinephrine and Epinephrine
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Molecular Mechanism for Agonist-Promoted α2A-Adrenoceptor Activation by Norepinephrine and Epinephrine

Tommi Nyrönen, Marjo Pihlavisto, Juha M. Peltonen, Anna-Marja Hoffrén, Minna Varis, Tiina Salminen, Siegfried Wurster, Anne Marjamäki, Liisa Kanerva, Erja Katainen, Leif Laaksonen, Juha-Matti Savola, Mika Scheinin and Mark S. Johnson
Molecular Pharmacology May 1, 2001, 59 (5) 1343-1354; DOI: https://doi.org/10.1124/mol.59.5.1343

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Molecular Mechanism for Agonist-Promoted α2A-Adrenoceptor Activation by Norepinephrine and Epinephrine

Tommi Nyrönen, Marjo Pihlavisto, Juha M. Peltonen, Anna-Marja Hoffrén, Minna Varis, Tiina Salminen, Siegfried Wurster, Anne Marjamäki, Liisa Kanerva, Erja Katainen, Leif Laaksonen, Juha-Matti Savola, Mika Scheinin and Mark S. Johnson
Molecular Pharmacology May 1, 2001, 59 (5) 1343-1354; DOI: https://doi.org/10.1124/mol.59.5.1343
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics